PRANAPTSD: Pranayama for Posttraumatic Stress Disorder

Sponsor
Universität Duisburg-Essen (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05645588
Collaborator
(none)
234
2
36

Study Details

Study Description

Brief Summary

This study aims to investigate the effect of pranayama (yoga-breathing techniques) on post-traumatic symptom severity in patients with post-traumatic stress disorder undergoing standard, out-patient, trauma-focused psychotherapy. Therefore, short pranayama sessions of 5-10 minutes will be provided to the patients directly at the begin of each of psychotherapy unit, while the control group will receive standard, trauma-focused psychotherapy alone.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Pranayama assisted trauma-focused standard psychotherapy (TF-SPT)
  • Behavioral: Trauma-focused standard psychotherapy (TF-SPT)
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
234 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Investigator, Outcomes Assessor)
Masking Description:
Participants and Therapists (Care Provider) could not be blinded according to the nature of the intervention. However, therapists will be blinded to allocation concealment as they do not be aware of the patients' group assignment at baseline assessment until they open the opaque randomization envelope, which contains the patient randomization number and group assignment. The random sequence generation and the envelopes were prepared by the study coordinator who is not involved patient recruitment. Patients received post intervention questionnaires from a study assistant/nurse of the respective outpatient department (outcome assessor) who is also blinded to the patients' group assignment. After completing the questionnaires, the study assistant will sent them to study coordinator so that the therapist could not influence the patients' answers.
Primary Purpose:
Treatment
Official Title:
Pranayama for Outpatients With Posttraumatic Stress Disorder: a Randomized-controlled Trial
Anticipated Study Start Date :
Feb 1, 2023
Anticipated Primary Completion Date :
Feb 1, 2025
Anticipated Study Completion Date :
Feb 1, 2026

Arms and Interventions

Arm Intervention/Treatment
Experimental: Pranayama assisted trauma-focused standard psychotherapy (TF-SPT).

Behavioral: Pranayama assisted trauma-focused standard psychotherapy (TF-SPT) The pranayama intervention is placed directly at the begin of the respective TF-SPT unit and will be repeated for 10 subsequent TF-SPT units.

Behavioral: Pranayama assisted trauma-focused standard psychotherapy (TF-SPT)
To prepare patients for the TF-SPT, they received 5-10 minutes of pranayama at the begin of each of the 10 TF-SPT units.

Active Comparator: Trauma-focused standard psychotherapy (TF-SPT)

Behavioral: Patients wait for 10 TF-SPT units and then are offered to learn pranayama.

Behavioral: Trauma-focused standard psychotherapy (TF-SPT)
Patients wait for 10 TF-SPT units and then are offered to learn pranayama

Outcome Measures

Primary Outcome Measures

  1. Intensity of posttraumtic symptoms [week 10]

    Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5): The PCL-5 is a standard 20-item scale with a sum score ranging from 0 to 80 points. The cut-off point for clinically relevant symptom severity is 33 points.

Secondary Outcome Measures

  1. Health-related quality of life [week 10]

    Short Form 12 Health Survey (SF-12): The SF-12 is a standard 12-item scale with two sum scores (physical and mental quality of life) ranging from 0 to 100 points.

  2. Anxiety [week 10]

    Beck Anxiety Inventory (BAI): The BAI is a standard 21-items scale ranging from 0 to 63 points with 0-7 points = minimal anxiety, 8-15 points = mild anxiety, 16-25 points = moderate anxiety, and 26-63 points = clinically relevant anxiety.

  3. Depression [week 10]

    Beck Depression Inventory Revision (BDI-II): The BDI-II is a standard 21-items scale ranging from 0 to 63 points with 0-13 points =no/clinically not relevant depression/depression in remission, 14-19 points = mild depression, 20-28 points = moderate depression und 29-63 points = severe depression.

  4. Breath Holding Duration [week 10]

    Breath Holding Task (BHT): The BHT is standard test procedure for the measurement of ability of the suppression of the respiratory reflex.

  5. Adverse Events [weeks 1,2,3,4,5,6,7,8,9,10]

    Number of patients with adverse events and types of the adverse events

  6. Therapist Global Improvement [week 10]

    Clinician Global Impression of Improvement (CGI-I) rated by the therapist on 1 item ranging from 1 to 7.

  7. Patient Global Improvement [week 10]

    Patient Global Impression of Improvement (PGI-I) rated by the patient on 1 item ranging from 1 to 7.

Other Outcome Measures

  1. Treatment Expectation [week 0]

    Treatment Credibility Scale (TCS): The TCS is a standard NRS scale ranging from 0 points (lowest expectation of treatment effectiveness) to 10 points (highest expectation of treatment effectiveness).

  2. Interoceptive Awareness [weeks 0+10]

    Multidimensional Assessment of Interoceptive Awareness, Version 2 (MAIA-II): The MAIA-II is a 37-item questionnaire. It includes 8 subscales. Scores ranged between 0 and 5, where higher score indicate more awareness of bodily sensation. Percentiles can also be calculated, indicating how the score is associated to a normative sample.

  3. Social Readjustment after life events [weeks 0+10]

    Social Readjustment Rating Scale (SRRS): The SRRS consists of 43 items. A sum score of 1-149 = low stress level; 150-299 = 30% probability of developing a stress-associated disease; 300 and more = 80% probability of developing a stress-associated disease.

  4. Compliance [weeks 0,1,2,3,4,5,6,7,8,9,10]

    Diary (via App): daily pranayama practice, BHT time

  5. Medication [weeks 0+10]

    A change in medication between weeks 0 and 10 is recorded.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Diagnosed PTSD according to ICD-10 F43.1

  • PCL-5 Score of at least 33 points

  • Undergoing outpatient standard trauma-focused psychotherapy (Cognitive Behavioral Therapy, Psychodynamic Psychotherapy, or Systemic Psychotherapy)

Exclusion Criteria:
  • Pre-existing mental or somatic conditions that are unlikely to result in correct or safe performance of pranayama:
  1. Substance dependence current use (ICD-10 F10.X, F11.X).

  2. Dementia (ICD-10 F00-F03)

  3. Somatoform Disorder (ICD F45.X) of moderate or severe degree according to DSM-5 300.82: ≥ 2 reactions (cognitive, emotional, or behavioral) to somatic symptoms (≥ 2 criterion-B)

  4. Severe cardiovascular disease: presence of cardiac or vascular implants or grafts, e.g., pacemaker (ICD-10 Z95.X), condition after organ or tissue transplantation (ICD-10 Z94.X)

  5. Acute adverse events occurring during pranayama at baseline (including neck pain, subjective sensation of pressure in the lungs, anxiety / panic)

  • Cancer diagnosis in the past 5 years (ICD-10 C00-C97, D37-48)

  • Pregnancy / breastfeeding

  • Regular pranayama practice in the last 12 months

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Universität Duisburg-Essen

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Heidemarie Haller, Director of Research, Universität Duisburg-Essen
ClinicalTrials.gov Identifier:
NCT05645588
Other Study ID Numbers:
  • 22-10859-BO
First Posted:
Dec 9, 2022
Last Update Posted:
Dec 16, 2022
Last Verified:
Dec 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Heidemarie Haller, Director of Research, Universität Duisburg-Essen
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 16, 2022